(GNVC) GENVEC News and A New Price Target!!!
February 24, 2010
– Comments (4) |
RELATED TICKERS: GNVC
Due to the recent news of Genvec (GNVC) getting the contract with the Department of Homeland Security and many other recent develeoping events.
GenVec Announces Contract With The Department of Homeland Security
GenVec Upward Momentum Looks to Continue (GNVC)Comtex Smartrend - Feb 22, 2010 I have increased my price target to $3.10 a share! With the recent price of 2.50 and the resistance at these levels. I see thing as a strong buy.
" GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. Using GenVec’s core adenovector technology, TNFerade stimulates the production of tumor necrosis factor alpha (TNFa), a known anti-tumor protein, in cells of the tumor. In addition to its therapeutic product development programs, GenVec is working with collaborators to develop new applications for its technology through its vaccine development programs. The Company is developing a vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus, and Herpes Simplex Virus Type 2 (HSV-2)." Buy any stock I recommend at your own risk. I assume no responsibility for your loss or mistakes
RSS Headlines
Fool UK